|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/4045 | (2013.01) | ||
| A61K 31/4045 | (2006.01) | ||
| A61K 31/428 | (2013.01) | ||
| A61K 31/48 | (2013.01) | ||
| A61K 31/428 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/48 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/7034 | (2013.01) | ||
| A61K 31/70 | (2006.01) | ||
| A61K 31/7042 | (2013.01) | ||
| A61K 31/7034 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61K 31/7042 | (2006.01) | ||
| A61K 31/7056 | (2013.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/70 | (2013.01) | ||
| A61K 31/7056 | (2006.01) | ||
| A61P 1/14 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 1/14 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Patento numeris | 3197429 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15774881.5 |
| Europos patento paraiškos padavimo data | 2015-09-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/071637 |
| Data | 2015-09-22 |
| (87) | Numeris | WO 2016/046150 |
| Data | 2016-03-31 |
| (30) | Numeris | Data | Šalis |
| 14186479 | 2014-09-25 | EP |
| (72) |
REICHE, Dania Birte , DE
RAHMEL, Daniela , DE
|
| (73) |
Boehringer Ingelheim Vetmedica GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE ANIMALS |
| COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE ANIMALS |